GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc. Analyst Price Targets - Benzinga

GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc.

GTBIFOTCQX

Trade with Public

Trade with Public

$7.68

0.202.67%

At close: Sep 4, 5:00 PM EST

$7.68

N/A

After Hours: Sep 4, 4:00 PM EST

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Compare

GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc. (GTBIF).

Price Target Range — 2 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$17Upside to Avg. PT+114.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 10, 2024	Wedbush	Gerald Pascarelli	PT Raise	Outperform	$15→$16
May 9, 2024	Needham	Matt McGinley	PT Raise	Buy	$16→$17
Feb 29, 2024	Needham	Matt McGinley	PT Raise	Buy	$11→$16
Nov 7, 2023	Zuanic & Associates	Pablo Zuanic	Initiate	Overweight	—

More with Benzinga EdgeGet Access

Analyst Ratings News

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

Nicolás Jose Rodriguez

85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading

85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2.

Nicolás Jose Rodriguez

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Nicolás Jose Rodriguez

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Nicolás Jose Rodriguez

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Nicolás Jose Rodriguez

Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning

The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.

Nicolás Jose Rodriguez